234 related articles for article (PubMed ID: 30700214)
21. Risk factors of infection-associated mortality in children with lupus nephritis in under-resourced areas.
Rianthavorn P; Prurapark P
Lupus; 2019 Dec; 28(14):1727-1734. PubMed ID: 31635558
[TBL] [Abstract][Full Text] [Related]
22. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
23. Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients.
Du K; Zhang X; Feng J; Zhong S; Qi J; Lin Z
Clin Rheumatol; 2022 Nov; 41(11):3363-3371. PubMed ID: 35854166
[TBL] [Abstract][Full Text] [Related]
24. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes.
Hanaoka H; Kuwana M; Takeuchi T
Int J Rheum Dis; 2015 Sep; 18(7):768-75. PubMed ID: 26179413
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis.
Zen M; Fuzzi E; Loredo Martinez M; Depascale R; Fredi M; Gatto M; Larosa M; Saccon F; Iaccarino L; Doria A
Rheumatology (Oxford); 2022 Feb; 61(2):688-695. PubMed ID: 33909900
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
27. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and outcome analysis of adult lupus nephritis patients in China.
Tang Y; Zhang X; Ji L; Mi X; Liu F; Yang L; Qin W
Int Urol Nephrol; 2015 Mar; 47(3):513-20. PubMed ID: 25563231
[TBL] [Abstract][Full Text] [Related]
30. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
31. Long-term data on tacrolimus treatment in lupus nephritis.
Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
34. Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV.
Hanaoka H; Kaneko Y; Kuwana M; Takeuchi T
Mod Rheumatol; 2015 Sep; 25(5):714-8. PubMed ID: 25563691
[TBL] [Abstract][Full Text] [Related]
35. Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis.
Okamoto M; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A; Ichinose K
Rheumatology (Oxford); 2021 May; 60(5):2333-2341. PubMed ID: 33166998
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome in Japanese patients with lupus nephritis.
Kono M; Yasuda S; Kato M; Kanetsuka Y; Kurita T; Fujieda Y; Otomo K; Horita T; Oba K; Kondo M; Mukai M; Yanai M; Fukasawa Y; Atsumi T
Lupus; 2014 Oct; 23(11):1124-32. PubMed ID: 24860121
[TBL] [Abstract][Full Text] [Related]
37. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.
Kwon OC; Park Y; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2019 Jan; 38(1):235-241. PubMed ID: 30094751
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
[TBL] [Abstract][Full Text] [Related]
39. Pediatric lupus nephritis: more options, more chances?
Vachvanichsanong P; McNeil E
Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
[TBL] [Abstract][Full Text] [Related]
40. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
Touma Z; Urowitz MB; Ibañez D; Gladman DD
J Rheumatol; 2014 Apr; 41(4):688-97. PubMed ID: 24429170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
